Evidence map›Paper›PMID 28538701›Full record

ArticleInternational journal of molecular sciences2017

Chlorpromazine Increases the Expression of Polysialic Acid (PolySia) in Human Neuroblastoma Cells and Mouse Prefrontal Cortex.

Chikara Abe, Saki Nishimura, Airi Mori, Yuki Niimi, Yi Yang, Masaya Hane, Ken Kitajima, Chihiro Sato

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Polysialylation in a DISC1 Mutant Mouse.International journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Chikara AbeBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. abe.chikara@f.mbox.nagoya-u.ac.jp.
Saki NishimuraBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. kenk@rj9.so-net.ne.jp.
Airi MoriBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. mori.airi@d.mbox.nagoya-u.ac.jp.
Yuki NiimiBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. the.one.p21@gmail.com.
Yi YangBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. yang.yi@j.mbox.nagoya-u.ac.jp.
Masaya HaneBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. hane.masaya@gmail.com.
Ken KitajimaBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. kitajima@agr.nagoya-u.ac.jp.
Chihiro SatoBioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan. chi@agr.nagoya-u.ac.jp.
Nagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neural cell adhesion molecule (NCAM) is modified by polysialic acid (polySia or PSA) in embryonic brains. In adult brains, polySia modification of NCAM is only observed in restricted areas where neural plasticity, remodeling of neural connections, or neural generation is ongoing although the amount of NCAM remains unchanged. Impairments of the polySia-expression and several single nucleotide polymorphisms (SNPs) of the polysialyltransferase (polyST) ST8SIA2 gene are reported to be associated with schizophrenia and bipolar disorder. Chlorpromazine (CPZ) is well-known as an agent for treating schizophrenia, and our hypothesis is that CPZ may affect the polySia expression or the gene expression of polySTs or NCAM. To test this hypothesis, we analyzed the effects of CPZ on the expression of polySia-NCAM on human neuroblastoma cell line, IMR-32 cells, by immunochemical and chemical methods. Interestingly, the cell surface expression of polySia, especially those with lower chain lengths, was significantly increased on the CPZ-treated cells, while mRNAs for polySTs and NCAM, and the amounts of total polySia-NCAM remained unchanged. The addition of brefeldin A, an inhibitor of endocytosis, suppressed the CPZ-induced cell surface polySia expression. In addition, polySia-NCAM was also observed in the vesicle compartment inside the cell. All these data suggest that the level of cell surface expression of polySia in IMR-32 is highly regulated and that CPZ changes the rate of the recycling of polySia-NCAM, leading to the up-regulation of polySia-NCAM on the cell surface. We also analyzed the effect of CPZ on polySia-expression in various brain regions in adult mice and found that CPZ only influenced the total amounts of polySia-NCAM in prefrontal cortex. These results suggest a brain-region-specific effect of CPZ on the expression of total polySia in mouse brain. Collectively, anti-schizophrenia agent CPZ consistently up-regulates the expression polySia at both cellular and animal levels.

Indexed as

AnimalsAntipsychotic AgentsCell Line, TumorChlorpromazineHumansMiceNeural Cell Adhesion MoleculesNeuronal PlasticityPolymorphism, Single NucleotidePrefrontal CortexSchizophreniaSialic AcidsSialyltransferasesUp-RegulationAntipsychotic AgentsChlorpromazineCMP-N-acetylneuraminate-poly-alpha-2,8-sialosyl sialyltransferaseNeural Cell Adhesion Moleculespolysialic acidSialic AcidsSialyltransferasesbrainneural cell adhesion moleculepolysialic acidpolysialyltransferaseschizophrenia

Identifiers

PMID28538701
PMCPMC5485947
OpenAlexW2620487371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.